DiscoverAll Things PolicyEp. 558: Supplying COVID-19 Therapeutics
Ep. 558: Supplying COVID-19 Therapeutics

Ep. 558: Supplying COVID-19 Therapeutics

Update: 2021-04-22
Share

Description

As urgent requests for convalescent plasma, Remdesivir and Tocilizumab increase, Ruturaj Gowaikar and Shambhavi Naik discuss the application of these therapeutics and the unnecessary shortage caused by poor public engagement over their utility.

If these policy conversations interest you, consider applying for Takshashila's Graduate Certificate in Public Policy. Applications for the monsoon cohort close soon. You can check out our courses here - www.takshashila.org.in/courses

You can follow Ruturaj Gowaikar on Twitter: @RuturajGowaikar

You can follow Shambhavi Naik on Twitter: @TheNaikMic

You can listen to this show and other awesome shows on the IVM Podcasts app on Android: https://ivm.today/android or iOS: https://ivm.today/ios, or any other podcast app

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Ep. 558: Supplying COVID-19 Therapeutics

Ep. 558: Supplying COVID-19 Therapeutics

IVM Podcasts